Dr. Goy on Developments in the Field of Immunology

Video

In Partnership With:

Andre Goy, MD, Chairman and Director and Chief of Lymphoma at John Theurer Cancer Center, comments on the recent developments in fighting cancer with the immune system.

Andre Goy, MD, Chairman and Director and Chief of Lymphoma at John Theurer Cancer Center, comments on the recent developments in fighting cancer with the immune system.

The effort to harness the immune system to fight cancers cells has had some success, though little has translated into lasting benefit. Recently, the development of immunology has focused on unleashing T cells and promoting their antitumor effect.

Immunology research has focused, among other things, on generating chimeric antigen T cells and developing monoclonal antibodies to unleash T cells. The oncology community, Goy says, believes that using the immune system is promising and could translate into great benefit for patients.

Related Videos
Corey Cutler, MD, MPH, and Hana Safah, MD, experts on GvHD
Shivaani Kummar, MBBS, FACP, Margaret and Lester DeArmond Endowed Chair of Cancer Research, Professor and Division Head, Division of Hematology/Medical Oncology, Oregon Health & Science University School of Medicine; co-director, Center for Experimental Therapeutics, co-deputy director, Knight Cancer Institute
Andre Goy, MD
Wenxin (Vincent) Xu, MD,
Guenther Koehne, MD, PhD
Alessandro Villa, DDS, PhD, MPH
Joseph Mikhael, MD
Michael Richardson, MD